Page last updated: 2024-11-05

2,4-dihydroxy-1,4-benzoxazin-3-one

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,4-dihydroxy-1,4-benzoxazin-3-one (DIBOA) is a natural product found in various plants, particularly in the Gramineae family, including maize. It is synthesized via the shikimate pathway, starting from L-phenylalanine. DIBOA exhibits strong antimicrobial activity against a wide range of fungi and bacteria, making it a potential natural fungicide. The compound also plays a role in plant defense against herbivores by inhibiting insect growth and development. Its antifungal and insecticidal properties have led to research on its potential for agricultural applications. Furthermore, DIBOA is known to possess antioxidant properties, which contribute to its potential health benefits. Research is ongoing to explore its therapeutic potential in various medical conditions, including cancer and neurodegenerative diseases. The complexity of DIBOA's synthesis and its diverse biological activities make it an interesting subject for research in plant biochemistry, natural product chemistry, and agricultural science.'

2,4-dihydroxy-1,4-benzoxazin-3-one: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

DIBOA : A lactol that consists of 1,4-benzoxazine bearing two hydroxy substituents at positions 2 and 4 as well as a keto group at position 3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID28495
CHEMBL ID483002
CHEBI ID63558
SCHEMBL ID914002
MeSH IDM0273715

Synonyms (24)

Synonym
brn 1077308
2h-1,4-benzoxazin-3(4h)-one, 2,4-dihydroxy-
2,4-dihydroxy-1,4-benzoxazinone
diboa
17359-54-5
2,4-dihydroxy-2h-1,4-benzoxazin-3(4h)-one
2,4-dihydroxy-1,4-benzoxazin-3-one
chebi:63558 ,
CHEMBL483002
unii-4j4378v66g
4j4378v66g ,
diboa cpd
SCHEMBL914002
AKOS024385513
(+/-)-diboa
2,4-dihydroxy-3,4-dihydro-2h-1,4-benzoxazin-3-one
2,4-dihydroxy-1,4-benzoxanzin-3(4h)-one
FT-0742172
2,4-dihydroxy-2h-benzo[b][1,4]oxazin-3(4h)-one
DTXSID90938409
Q27132689
A847296
EN300-5268251
Z1486012699

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" by root allelopathy in a dose-response bioassay."( Differential exudation of two benzoxazinoids--one of the determining factors for seedling allelopathy of Triticeae species.
Belz, RG; Hurle, K, 2005
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
phytotoxinAny toxin produced by a plant.
herbicideA substance used to destroy plant pests.
allelochemicalA class of secondary metabolites developed by many plants to influence the behaviour, growth or survival of herbivores, and thus acting as a defence against herbivory.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
benzoxazine
cyclic hydroxamic acidA lactam having a hydroxy substituent on the amide nitrogen.
lactolCyclic hemiacetals formed by intramolecular addition of a hydroxy group to an aldehydic or ketonic carbonyl group. They are thus 1-oxacycloalkan-2-ols or unsaturated analogues.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
DIBOA-glucoside biosynthesis713
superpathway of benzoxazinoid glucosides biosynthesis920

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1103171Antifeedant activity against third-instar larvae of Rhopalosiphum padi assessed as repellency index after 24 hr by feeding choice assay2004Journal of agricultural and food chemistry, May-05, Volume: 52, Issue:9
Chemical basis for the antifeedant activity of natural hydroxamic acids and related compounds.
AID1585947Antifungal activity against Candida albicans after 24 hrs by spectrophotometric method2018Bioorganic & medicinal chemistry, 12-15, Volume: 26, Issue:23-24
QSAR of 1,4-benzoxazin-3-one antimicrobials and their drug design perspectives.
AID1585945Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by disk diffusion method2018Bioorganic & medicinal chemistry, 12-15, Volume: 26, Issue:23-24
QSAR of 1,4-benzoxazin-3-one antimicrobials and their drug design perspectives.
AID1585946Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by disk diffusion method2018Bioorganic & medicinal chemistry, 12-15, Volume: 26, Issue:23-24
QSAR of 1,4-benzoxazin-3-one antimicrobials and their drug design perspectives.
AID1585944Antifungal activity against Candida albicans after 24 hrs by disk diffusion method2018Bioorganic & medicinal chemistry, 12-15, Volume: 26, Issue:23-24
QSAR of 1,4-benzoxazin-3-one antimicrobials and their drug design perspectives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (10.00)18.2507
2000's20 (66.67)29.6817
2010's6 (20.00)24.3611
2020's1 (3.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.30

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.30 (24.57)
Research Supply Index3.61 (2.92)
Research Growth Index4.91 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.30)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.86%)5.53%
Reviews1 (2.86%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other33 (94.29%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]